Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sept 18 (Reuters) — NAVER D2SF: Naver D2sf Invests In Ai-driven Precision Medicine Company Imprimed Naver D2sf: Invests In Imprimed In $10 Million Series A2 Bridge Round Naver D2sf: Imprimed $10 Million Bridge Round Led By Lb Investment With Naver D2sf, Samsung Securities, Alois Ventures ((( Reuters.Briefs@thomsonreute
Naver D2SF said it is investing $10 million in ImpriMed’s Series A2 bridge round.
Naver’s venture arm D2SF invested in precision medicine startup ImpriMed, taking a minority stake in a USD 10 million Series A2 bridge round. Funding targets ImpriMed’s U.S. commercialization in AI-driven precision oncology, with expansion plans into Asia. ImpriMed is preparing FDA clearance and CLIA certification by Q